REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmasi C S (Station 18) Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmasi C S (Station 18) Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Farmasi C S (Station 18) Sdn. Bhd. is based in Malaysia, with the head office in Ipoh. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on January 25, 2017. Its’ total assets recorded a negative growth of 2.78%.

Headquarters
50-52, Jalan Pengakalan Barat 32, Taman Pengkalan Jaya
Ipoh; Perak; Postal Code: 31650

Contact Details: Purchase the Farmasi C S (Station 18) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Farmasi C S (Station 18) Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Farmasi C S (Station 18) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Farmasi C S (Station 18) Sdn. Bhd. report to view the information.
Incorporation Date:
January 25, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Farmasi C S (Station 18) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
14.94%
EBITDA
23.92%
Net Profit (Loss) for the Period
15.17%
Total assets
-2.78%
Total equity
48.74%
Return on Equity (ROE)
-9.55%
Quick Ratio
0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?